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Abstract
Problem/Condition: Cryptosporidiosis, a gastrointestinal illness, is caused by protozoa of the genus Cryptosporidium.
Reporting Period: 1999–2002.
System Description: State and two metropolitan health departments voluntarily reported cases of cryptosporidiosis
through CDC’s National Electronic Telecommunications System for Surveillance.
Results: During 1999–2002, the total number of reported cases of cryptosporidiosis increased from 2,769 for 1999 to
3,787 for 2001 and then decreased to 3,016 for 2002. The number of states reporting cryptosporidiosis cases increased
from 46 to 50, and the number of states reporting more than four cases per 100,000 population increased from two to
five. A greater number of case reports were received for children aged 1–9 years and for adults aged 30–39 years
compared with other age groups. Incidence of cryptosporidiosis was particularly high in the upper Midwest and
Vermont. Peak onset of illness occurred annually during early summer through early fall.
Interpretation: Transmission of cryptosporidiosis occurs throughout the United States, with increased diagnosis or
reporting occurring in northern states. However, state incidence figures should be compared with caution because
individual state surveillance systems have varying capabilities to detect cases. The seasonal peak in age-specific case
reports coincides with the summer recreational water season and might reflect increased use of communal swimming
venues (e.g., lakes, rivers, swimming pools, and water parks) by young children.
Public Health Action: Cryptosporidiosis surveillance provides data to educate public health practitioners and health-
care providers about the epidemiologic characteristics and the disease burden of cryptosporidiosis in the United States.
These data are used to improve reporting of cases, plan prevention efforts, and establish research priorities.
Florida), the only drug approved in the United States for treat-
ing cryptosporidiosis, can be used solely to treat children aged
1–11 years (4).
A zoonotic disease, cryptosporidiosis also affects domestic
(e.g., dogs, cattle, and sheep) and wild animals. Crypto-
sporidium hominus (known previously as Cryptosporidium
parvum genotype I) naturally infects only humans, whereas
Cryptosporidium parvum (known previously as Cryptosporidium
parvum genotype II) infects both humans and cattle (5).
Infected cattle serve as an important reservoir of C. parvum
and therefore are substantial contributors to sporadic human
cryptosporidiosis (6,7). Use of the term Cryptosporidium
denotes either species unless otherwise noted.
Cryptosporidium infection is transmitted by the fecal-oral
route and results from the ingestion of Cryptosporidium
oocysts through the consumption of fecally contaminated food
or water or through person-to-person or animal-to-person
transmission. The oocysts are infectious immediately upon
being excreted in feces. The infectious dose is low; ingestion
Introduction
Cryptosporidiosis is a gastrointestinal illness caused by coc-
cidian protozoa of the genus Cryptosporidium (1). The hall-
mark symptom of this disease is diarrhea, which can be
accompanied by abdominal cramps, loss of appetite, low-grade
fever, nausea, vomiting, and weight loss; however, asymptom-
atic infection occurs frequently (2). Cryptosporidium can also
cause an opportunistic infection in human immunodeficiency
virus (HIV)–infected patients, who might experience life-
threatening infection with profuse, watery, cholera-like diar-
rhea. The incidence of this parasitic infection among the
HIV-infected population, however, has decreased since the
introduction of highly active antiretroviral therapy (HAART)
for treating persons with HIV infection (3). Nitazoxanide
(NTZ, Alinia™, Romark Laboratories, L.C.; Tampa Bay,
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2 MMWR January 28, 2005
of as few as 10–30 oocysts has been reported to cause infec-
tion in healthy persons (8,9). Certain infected persons have
been reported to shed <109 oocysts in their stool per day and
to excrete oocysts for <15 days after their symptoms have
resolved (10,11).
Persons at increased risk for infection include 1) persons
who have contact with infected animals, 2) persons who have
ingested contaminated recreational (e.g., lake, river, pool, or
hot tub) or drinking water, 3) close contacts of infected per-
sons (e.g., those in the same family or household or in child
care settings), and 4) travelers to disease-endemic areas (1,6).
Although cryptosporidiosis cases can occur sporadically,
outbreaks are well documented. During 1991–2000,
Cryptosporidium was identified as a causal agent of 37.7% (40
of 106) of reported recreational water-associated and 8.5%
(11 of 130) of reported drinking water-associated outbreaks
of gastroenteritis of known and suspected infectious etiology*
(12–16). Additionally, foodborne outbreaks of crypto-
sporidiosis linked to ill foodhandlers and unpasteurized apple
cider have been reported (17,18). Outbreaks resulting from
person-to-person transmission in child care centers and from
animal-to-person transmission in an animal nursery also have
been reported (19,20).
Reporting of cryptosporidiosis as a nationally notifiable dis-
ease began in 1995. This report summarizes national
cryptosporidiosis surveillance data for 1999–2002.
Methods
Laboratory-confirmed cases of cryptosporidiosis can be
reported voluntarily to CDC. Laboratory-confirmed crypto-
sporidiosis is defined as the detection (in symptomatic or
asymptomatic persons) of Cryptosporidium
• oocysts in stool or intestinal fluid by microscopic exami-
nation with or without staining (e.g., modified acid-fast)
or by fluorescent antibody assays, either direct (DFA) or
indirect (IFA); or
• oocyst or sporozoite antigens in stool or intestinal fluid
by immunodiagnostic methods (e.g., enzyme immunoas-
say [EIA]); or
• parasite DNA in stool, in intestinal or other bodily fluids
(e.g. bile or sputum), or in tissue samples by polymerase
chain reaction (PCR) techniques when available; or
• life-cycle stages (e.g. trophozoites or merozoites) in tissue
samples (21).
Testing for cryptosporidiosis should be specifically requested
because it is not always included in routine examination of
stool for ova and parasites (1). DFA is the most sensitive and
the most specific detection method; however, other
immunodiagnostic kits that do not require microscopy (e.g.,
EIA and rapid immunochromatographic cartridge assays) are
also available (22). Only genetic testing (e.g., PCR) can be
used to speciate isolates of Cryptosporidium.
State, District of Columbia (DC), New York City (NYC),
commonwealth, and territorial health departments can vol-
untarily report laboratory-confirmed cases of cryptosporidiosis
to CDC through the National Electronic Telecommunications
System for Surveillance (NETSS). Reports include the patient’s
geographic information (i.e., state and county), age, sex, race,
ethnicity (i.e., Hispanic or non-Hispanic) and date of illness
onset and indicate whether the case is related to a known out-
break. An outbreak-related case is a laboratory-confirmed case
that is linked epidemiologically to another laboratory-
confirmed case. The patient’s HIV-status is not reported to
CDC.
Analysis of national cryptosporidiosis surveillance data for
1999–2002 was conducted by using SAS® v 8.2 (SAS Insti-
tute Inc.; Cary, North Carolina) and the Food Safety Infor-
mation Link (FSI Link). FSI Link, an intranet-based tool
available to CDC staff, provides access to NETSS data and is
used to monitor trends in, and investigate outbreaks of,
reportable foodborne and waterborne diseases.
Results
During the reporting period 1999–2002, the total number
of reported cases of cryptosporidiosis increased 36.8% from
2,769 in 1999 to 3,787 in 2001 and then decreased 20.4% to
3,016 in 2002 (Table 1). Cases reported to be outbreak
related made up 10.3%–13.7% of the total number of cases
reported annually for 1999–2001 and 6.9% of the total
reported for 2002. The number of states reporting
cryptosporidiosis cases increased from 46 to 50 during the
reporting period, and the number of states reporting more
than four cases per 100,000 population increased from two
in 1999 to five in 2002.
For 2002, incidence of cryptosporidiosis ranged from 0.2
cases (multiple states) to 9.5 cases (Wisconsin) per 100,000
population, with Minnesota, North Dakota, South Dakota,
Vermont, and Wisconsin each reporting more than four cases
per 100,000 population (Figure 1) (Table 1). Wisconsin
reported the greatest number of cases per 100,000 population
for each of the 4 years of the reporting period.
These surveillance data display a bimodal age distribution,
with the greatest number of reported cases occurring among
* The denominator includes outbreaks whose etiology was reported to be
acute gastrointestinal illness because they were suspected to be caused by
an unidentified infectious agent.
Vol. 54 / SS-1 Surveillance Summaries 3
TABLE 1. Cryptosporidiosis case reports, by state/area — United States, 1999–2002
1999 2000 2001 2002
No. of No. of No. of No. of
outbreak outbreak outbreak outbreak
State/Area No. (%) Rate* cases No. (%) Rate cases No. (%) Rate cases No. (%) Rate cases
Alabama 16 (0.6) 0.4 16 (0.5) 0.4 18 (0.5) 0.4 47 (1.6) 1.0
Alaska NR† NR 1 (<0.1) 0.2 1 (<0.1) 0.2
Arizona 16 (0.6) 0.3 10 (0.3) 0.2 11 (0.3) 0.2 19 (0.6) 0.3
Arkansas 2 (0.1) 0.1 16 (0.5) 0.6 10 (0.3) 0.4 8 (0.3) 0.3
California 279 (10.1) 0.8 235 (7.5) 0.7 229 (6.0) 0.7 200 (6.6) 0.6
Colorado 14 (0.5) 0.3 72 (2.3) 1.7 14 44 (1.2) 1.0 57 (1.9) 1.3
Connecticut 22 (0.8) 0.6 29 (0.9) 0.9 17 (0.4) 0.5 19 (0.6) 0.5
Delaware 1 (<0.1) 0.1 9 (0.3) 1.1 6 (0.2) 0.8 4 (0.1) 0.5
District of Columbia 7 (0.3) 1.2 18 (0.6) 3.1 14 (0.4) 2.4 5 (0.2) 0.9
Florida 189 (6.8) 1.2 186 240 (7.7) 1.5 233 91 (2.4) 0.6 106 (3.5) 0.6 97
Georgia 170 (6.1) 2.1 191 (6.1) 2.3 162 (4.3) 1.9 123 (4.1) 1.4
Hawaii NR NR 3 (0.1) 0.2 3 2 (0.1) 0.2 2
Idaho 8 (0.3) 0.6 28 (0.9) 2.2 23 (0.6) 1.7 29 (1.0) 2.2
Illinois 90 (3.3) 0.7 126 (4.0) 1.0 483 (12.8) 3.9 341 121 (4.0) 1.0
Indiana 47 (1.7) 0.8 1 72 (2.3) 1.2 90 (2.4) 1.5 70 (2.3) 1.1
Iowa 56 (2.0) 1.9 77 (2.5) 2.6 82 (2.2) 2.8 49 (1.6) 1.7
Kansas 2 (0.1) 0.1 9 (0.3) 0.3 4 (0.1) 0.1 16 (0.5) 0.6
Kentucky 7 (0.3) 0.2 7 7 (0.2) 0.2 7 5 (0.1) 0.1 5 10 (0.3) 0.2 10
Louisiana 24 (0.9) 0.5 14 (0.4) 0.3 8 (0.2) 0.2 10 (0.3) 0.2
Maine 31 (1.1) 2.4 20 (0.6) 1.6 19 (0.5) 1.5 12 (0.4) 0.9
Maryland 17 (0.6) 0.3 14 (0.4) 0.3 40 (1.1) 0.7 19 (0.6) 0.3
Massachusetts 71 (2.6) 1.1 55 37 (1.2) 0.6 2 55 (1.5) 0.9 77 (2.6) 1.2 2
Michigan 52 (1.9) 0.5 97 (3.1) 1.0 187 (4.9) 1.9 135 (4.5) 1.3
Minnesota 91 (3.3) 1.9 2 190 (6.1) 3.9 4 197 (5.2) 4.0 11 206 (6.8) 4.1 32
Mississippi 12 (0.4) 0.4 16 (0.5) 0.6 15 (0.4) 0.5 10 (0.3) 0.3
Missouri 26 (0.9) 0.5 31 (1.0) 0.6 55 (1.5) 1.0 41 (1.4) 0.7
Montana 13 (0.5) 1.4 10 (0.3) 1.1 37 (1.0) 4.1 6 (0.2) 0.7
Nebraska 15 (0.5) 0.9 82 (2.6) 4.8 185 (4.9) 10.8 52 (1.7) 3.0
Nevada 9 (0.3) 0.5 4 4 (0.1) 0.2 3 7 (0.2) 0.3 4 (0.1) 0.2
New Hampshire 20 (0.7) 1.6 20 25 (0.8) 2.0 25 17 (0.4) 1.4 17 31 (1.0) 2.4 31
New Jersey 54 (2.0) 0.6 19 (0.6) 0.2 24 (0.6) 0.3 17 (0.6) 0.2
New Mexico 44 (1.6) 2.4 25 (0.8) 1.4 30 (0.8) 1.6 20 (0.7) 1.1
New York§ 452 (16.3) 2.4 4 310 (9.9) 1.6 248 (6.5) 1.3 4 300 (9.9) 1.6 3
  New York City 260 (9.4) 3.5 171 (5.5) 2.1 123 (3.2) 1.5 147 (4.9) 1.8
North Carolina 35 (1.3) 0.4 4 28 (0.9) 0.3 31 (0.8) 0.4 40 (1.3) 0.5 1
North Dakota 20 (0.7) 3.1 18 (0.6) 2.8 15 (0.4) 2.4 41 (1.4) 6.5
Ohio 67 (2.4) 0.6 260 (8.3) 2.3 134 185 (4.9) 1.6 119 (3.9) 1.0
Oklahoma 14 (0.5) 0.4 30 (1.0) 0.9 16 (0.4) 0.5 16 (0.5) 0.5
Oregon 98 (3.5) 2.9 61 20 (0.6) 0.6 58 (1.5) 1.7 40 (1.3) 1.1
Pennsylvania 123 (4.4) 1.0 64 (2.0) 0.5 102 (2.7) 0.8 111 (3.7) 0.9
Rhode Island 6 (0.2) 0.6 4 (0.1) 0.4 10 (0.3) 0.9 21 (0.7) 2.0
South Carolina NR NR 7 (0.2) 0.2 8 (0.3) 0.2
South Dakota 7 (0.3) 0.9 15 (0.5) 2.0 8 (0.2) 1.1 42 (1.4) 5.5 22
Tennessee 13 (0.5) 0.2 12 (0.4) 0.2 24 (0.6) 0.4 61 (2.0) 1.1
Texas 69 (2.5) 0.3 115 (3.7) 0.6 96 (2.5) 0.4 34 (1.1) 0.2
Utah 4 (0.1) 0.2 28 (0.9) 1.3 1 84 (2.2) 3.7 16 (0.5) 0.7
Vermont 36 (1.3) 6.0 7 28 (0.9) 4.6 34 (0.9) 5.5 33 (1.1) 5.4
Virginia 30 (1.1) 0.4 21 (0.7) 0.3 27 (0.7) 0.4 35 (1.2) 0.5
Washington NR NR NR 46 (1.5) 0.8
West Virginia 3 (0.1) 0.2 3 (0.1) 0.2 2 (0.1) 0.1 3 (0.1) 0.2
Wisconsin 386 (13.9) 7.2 2 428 (13.7) 8.0 5 664 (17.5) 12.3 6 515 (17.1) 9.5 5
Wyoming 1 (<0.1) 0.2 5 (0.2) 1.0 7 (0.2) 1.4 2 9 (0.3) 1.8 2
Total 2,769 (100.0)¶ 1.0 353 3,128 (100.0) 1.1 428 3,787 (100.0) 1.3 389 3,016 (100.0) 1.0 207
Sources: Population estimates are from the Population Division, US Census Bureau. Estimates of the population of states: ST-99-4 State Rankings of Population Change and
Demographic Components of Population Change for the Period July 1, 1998, to July 1, 1999, available at http://www.census.gov/popest/archives/1990s/ST-99-01.txt, and Table 1:
Annual estimates of the population for the United States and States and Puerto Rico: April 1, 2001, to July 1, 2003 (NST-EST 2003 01), available at http://www.census.gov/popest/
states/tables/NST-EST2003-01.xls. Estimates of the New York City population: (SU-99-7) Population Estimates for Places (Sorted Alphabetically Within State): Annual Time Series,
July 1, 1990 to July 1, 1999 (includes April 1, 1990 Population Estimates Base), available at http://www.census.gov/popest/archives/1990s/su-99-07/SU-99-7_NY.txt, and Table 1:
Annual Estimates of the Population for Incorporated Places over 100,000, Ranked by July 1, 2003 Population: April 1, 2001, to July 1, 2003 (SUB-EST 2003-01), available at
http://www.census.gov/popest/cities/tables/SUB-EST2003-01.xls.
* Per 100,000 population on the basis of U.S. Census Bureau population estimates.
† No cases reported.
§ New York State case counts include New York City cases.
¶ Percentages might not total 100% because of rounding.
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FIGURE 1. Incidence* of cryptosporidiosis, by state — United
States, 2002
* Per 100,000 population.
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children aged 1–4 and 5–9 years and among adults aged 30–34
and 35–39 years (Figure 2). When reports for which patients’
sex was unknown or missing are excluded, the percentage of
cases reported to have occurred among males varied annually
from 53.5% (2,002 of 3,745) for 2001 to 58.9% (1,623 of
2,755) for 1999 (Table 2).
A five- to sixfold increase in reported cryptosporidiosis cases
by illness onset occurred during June–October (i.e., weeks
25–42 [early summer through early fall]) compared with Janu-
ary–March (Figure 3). However, the date of illness onset was
indicated for only 56.6% (1,567 of 2,769) of reported cases
for 1999, for 51.7% (1,616 of 3,128) for 2000, for 60.6%
(2,296 of 3,787) for 2001, and for 59.4% (1,791 of 3,016)
for 2002. Age-specific analysis indicated that the seasonality
in onset of illness was exhibited particularly among children
aged 1–4 and 5–9 years (Figure 4) and across all age groups.
The majority of cases for which data on race were available
for 1999–2002 occurred among whites, followed by blacks,
Asians and Pacific Islanders, and Native Americans (Table 2).
However, data on race were lacking for 28.2%–36.5% of the
total annual case reports. Of patients for whom data on
ethnicity were reported, 9.8%–12.8% (185 of 1,889 for 2001
and 213 of 1,660 for 1999, respectively) were reported to be
Hispanic (Table 2). However, data on ethnicity were lacking
for 39.6%–50.1% of the total annual case reports for 1999–
2002.
Discussion
National cryptosporidiosis surveillance data are used to
assess the epidemiologic characteristics and disease burden of
cryptosporidiosis in the United States. The total number of
cases reported annually increased during 1999–2001 and then
decreased in 2002. Whether this decrease reflects changes in
reporting patterns and behavior or a real change in infection
and disease caused by Cryptosporidium is unclear. FoodNet
data document a decrease in case reports of cryptosporidiosis
and other enteric diseases for 1996–2003; this decrease has
been attributed to increased government and food industry
emphasis on improved food safety (23).
Cryptosporidiosis is geographically
widespread in the United States. These
data and data from the previous
national cryptosporidiosis surveillance
summary (1995–1998) indicate that
the diagnosis or transmission of
cryptosporidiosis might be higher in
northern states (24). However, differ-
ences in cryptosporidiosis surveillance
systems among states can affect the
capability to detect cases, making
interpretation of this observation dif-
ficult.
Although cryptosporidiosis affects
persons in all age groups, the number
of reported cases was highest among
children aged 1–9 years and adults aged
30–39 years. These data are consistent
with reports of cryptosporidiosis inci-
dence being higher among younger
children and of transmission to their
FIGURE 2. Number of cryptosporidiosis case reports, by age group and year —
United States, 1999–2002
0
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* Case reports decreased with increased age.
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caregivers (e.g., child care staff, family members, and other
household contacts) (19,24–26).
A marked seasonality in the onset of illness occurs in early
summer through early fall, and a five- to sixfold increase in
transmission of cryptosporidiosis occurs during the summer.
This increase coincides with increased outdoor activities (e.g.,
swimming during the summer recreational water season) and
might reflect heavy use of community swimming (essentially
communal bathing) venues by younger children (6,12–16).
Cryptosporidium is the leading cause of reported recreational
water-associated outbreaks of gastroenteritis; transmission
through recreational water is facilitated by the substantial
number of Cryptosporidium oocysts that can be shed by a single
person; the extended periods of time that oocysts can be shed;
the low infectious dose; the resistance of Cryptosporidium
oocysts to chlorine; and the prevalence of improper pool main-
tenance (i.e., insufficient disinfection, filtration, and recircu-
lation of water), particularly of children’s wading pools
(8–16,27,28). This seasonal variation also has been noted in
state, Canadian provincial, and previous U.S. national sur-
veillance data for cryptosporidiosis, as well as for giardiasis
(24–26,29).
Although the reason is unknown, increased transmission
appears to occur among males, a finding that has been
reported repeatedly (24–26). Because data on race and
ethnicity are incomplete, conclusions cannot be made about
differences in the epidemiology of cryptosporidiosis among
TABLE 2. Number and percentage* of cryptosporidiosis case reports, by selected demographic characteristics — United States,
1999–2002
1999 2000 2001 2002
Characteristic No. (%) No. (%) No. (%) No. (%)
Sex
  Male 1,623 (58.6) 1,753 (56.0) 2,002 (52.9) 1,658 (55.0)
  Female 1,132 (40.9) 1,341 (42.9) 1,743 (46.0) 1,301 (43.1)
  Unknown/Missing 14 (0.5) 34 (1.1) 42 (1.1) 57 (1.9)
  Total 2,769 (100.0) 3,128 (100.0) 3,787 (100.0) 3,016 (100.0)
Race
  Native American 4 (0.1) 6 (0.2) 18 (0.5) 11 (0.4)
  Asian/Pacific Islander 27 (1.0) 32 (1.0) 30 (0.8) 26 (0.9)
  Black 280 (10.1) 322 (10.3) 301 (7.9) 267 (8.9)
  White 1,481 (53.5) 1,807 (57.8) 2,026 (53.5) 1,842 (61.1)
  Other 19 (0.7) 14 (0.4) 29 (0.8) 17 (0.6)
  Unknown/Missing 958 (34.6) 947 (30.3) 1,383 (36.5) 853 (28.2)
  Total 2,769 (100.0) 3,128 (100.0) 3,787 (100.0) 3,016 (100.0)
Ethnicity
  Hispanic 213 (7.7) 187 (6.0) 185 (4.9) 182 (6.0)
  Non-Hispanic 1,447 (52.3) 1,576 (50.4) 1,704 (45.0) 1,639 (54.3)
  Unknown/Missing 1,109 (40.1) 1,365 (43.6) 1,898 (50.1) 1,195 (39.6)
  Total 2,769 (100.0) 3,128 (100.0) 3,787 (100.0) 3,016 (100.0)
*Percentages might not total 100% because of rounding.
FIGURE 4. Number of cryptosporidiosis case reports, by
selected age group* and date of illness onset — United States,
1999–2002
* The 1–4 and 5–9 year age groups are presented because they have the
highest numbers of cryptosporidiosis case reports and the greatest
seasonality. The 35–39 year age group was chosen to illustrate the less
pronounced seasonality of the other age groups.
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FIGURE 3. Number of cryptosporidiosis case reports, by date
of illness onset — United States, 1999–2002
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members of different racial populations and between Hispan-
ics and non-Hispanics.
The data reported likely underestimate the cryptosporidiosis
burden in the United States. Diarrheal diseases are highly
underreported because 1) not all infected persons are symp-
tomatic; 2) those who are symptomatic do not always seek
medical care; 3) health-care providers do not always include
diagnostics in their workup of diarrheal diseases because they
might treat patients without testing stool for the pathogen;
and 4) case-reports are not always completed for positive labo-
ratory results or forwarded to public health officials (30).
An estimated 1%–5% of cases of salmonellosis, another
diarrheal illness, are reported to CDC through passive sur-
veillance (31). If these estimates are used to extrapolate from
the 3,016 cryptosporidiosis cases reported by the 50 states
and DC for 2002, the cryptosporidiosis disease burden in the
United States in 2002 could have been 60,320–301,600 cases
(20.9–104.7 cases per 100,000 population). The true burden
of cryptosporidiosis in the United States is likely to fall
between these two estimates.
Its low infectious dose, protracted communicability, and
chlorine resistance make Cryptosporidium ideally suited for
transmission through drinking and recreational water, food,
and both person-to-person and animal-to-person contact. Pre-
vention measures (Box 1) and measures to improve surveil-
lance for cryptosporidiosis and increase understanding of its
epidemiology and the associated disease burden (Box 2) have
been recommended. Information about cryptosporidiosis is
available from CDC at http://www.cdc.gov/ncidod/dpd/para-
sites/cryptosporidiosis/factsht_cryptosporidiosis.htm.
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BOX 1. Recommendations to prevent and control cryptosporidiosis
Always practice good hand hygiene.
• Wash hands with soap and water for at least 15 seconds,
rubbing hands together vigorously and scrubbing all
surfaces
— after using the toilet,
— before handling food,
— after every diaper change (even if wearing gloves),
— after direct contact with preschool-aged children,
and
— after any contact with animals or their feces.
Prevent contamination of recreational water (e.g.,
swimming pools, spas, interactive fountains, lakes,
rivers, and oceans).
• Do not swim when ill with diarrhea (e.g., swimming in
or entering the water at pools, spas, interactive foun-
tains, lakes, rivers, or oceans).
• Take children on frequent bathroom breaks and check
their diapers often.
• Change diapers in the bathroom, not at the poolside.
• Wash children thoroughly (especially their bottoms) with
soap and water after they use the toilet or their diapers
are changed and before they enter the water.
• Shower before entering the water.
Information about recreational water illnesses (RWIs)
and how to stop them from spreading is available from
CDC at http://www.cdc.gov/healthyswimming.
Prevent infection and illness caused by water that might
be contaminated.
• Do not swallow water in swimming pools, spas, and
interactive fountains.
• Do not swallow untreated water from lakes, rivers,
springs, ponds, streams, or shallow wells.
• Do not drink inadequately treated water during
communitywide outbreaks caused by contaminated
drinking water.
• Do not use or drink inadequately treated water when
traveling in countries where the water supply might be
unsafe.
• If the safety of drinking water is in doubt,
— disinfect it by heating the water to a rolling boil for
1 minute, or
— use a filter that has been tested and rated by
National Safety Foundation (NSF) Standard 53 or
NSF Standard 58 for cyst reduction; filtered water
will need additional treatment to kill or inactivate
bacteria and viruses.
Information about water filters and bottled water is
available from CDC at http://www.cdc.gov/ncidod/dpd/
parasites/cryptosporidiosis/factsht_crypto_prevent_
water.htm.
Prevent infection and illness caused by eating food that
might be contaminated.
• Use properly treated water to wash all food that will be
eaten raw.
• Do not eat uncooked foods when traveling in areas where
cryptosporidiosis is common.
Prevent contact and contamination with feces during
sex.
• Use a barrier (e.g., a condom) during oral-anal sex.
• Wash hands immediately after handling a condom used
during anal sex and after touching the anus or rectal area.
Additional recommendations for prevention and con-
trol of cryptosporidiosis for persons with compromised
immune systems.
• Minimize contact with the stool of all animals, particu-
larly young animals.
— Have others change litter boxes and clean cages.
— Wear disposable gloves when cleaning up after a
pet and always wash hands when finished.
• Wash hands after any contact with animals or their
living areas.
• Wash hands after gardening, even if wearing gloves.
• Wash, peel, and, if needed, cook, all raw vegetables.
• Boil or filter drinking water to ensure its safety, particu-
larly in an area experiencing an outbreak; filtered water
will need additional treatment to kill or inactivate
bacteria and viruses.
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BOX 2. Recommended measures to improve surveillance for
cryptosporidiosis and increase understanding of its
epidemiology and associated disease burden
• Encourage health-care providers to consider and specifi-
cally request testing for Cryptosporidium in the workup
of gastrointestinal illness.
• Encourage laboratories to test for Cryptosporidium when
examining stool for ova and parasites.
• Continue to educate health-care providers as well as
public and private laboratories to improve reporting of
cases of cryptosporidiosis to jurisdictional health depart-
ments.
• Encourage jurisdictional health departments to trans-
mit cryptosporidiosis data to CDC through the National
Electronic Disease Surveillance System (NEDSS), which
will replace the National Electronic Telecommunications
System for Surveillance (NETSS).
• Publish and distribute cryptosporidiosis surveillance data
regularly for public health education purposes.
• Conduct further epidemiologic studies of the geographic
variability, incidence, and risk factors for cryptosporidiosis.
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Abstract
Problem/Condition: Giardiasis, a gastrointestinal illness, is caused by the protozoan parasite Giardia intestinalis.
Reporting Period: 1998–2002.
System Description: State, commonwealth, territorial, and two metropolitan health departments voluntarily reported
cases of giardiasis through CDC’s National Electronic Telecommunications System for Surveillance.
Results: During 1998–2002, the total number of reported cases of giardiasis decreased from 24,226 for 1998 to
19,708 for 2001 and then increased to 21,300 for 2002. The number of states reporting giardiasis cases increased from
42 to 46; however, the number of states reporting more than 15 cases per 100,000 population decreased from 10 to
five. A greater number of case reports were received for children aged 1–9 years and for adults aged 30–39 years
compared with other age groups. Incidence of giardiasis was highest in northern states. Peak onset of illness occurred
annually during early summer through early fall.
Interpretation: The increase observed for 2002 might reflect increased reporting after reporting of giardiasis as a
nationally notifiable disease began in 2002. Transmission of giardiasis occurs throughout the United States, with
increased diagnosis or reporting occurring in northern states. However, state incidence figures should be compared
with caution because individual state surveillance systems have varying capabilities to detect cases. The seasonal peak in
age-specific case reports coincides with the summer recreational water season and might reflect increased use of com-
munal swimming venues (e.g., lakes, rivers, swimming pools, and water parks) by young children.
Public Health Action: Giardiasis surveillance provides data to educate public health practitioners and health-care
providers about the epidemiologic characteristics and the disease burden of giardiasis in the United States. These data
are used to improve reporting of cases, plan prevention efforts, and establish research priorities.
person-to-person or animal-to-person transmission. The cysts
are infectious immediately upon being excreted in feces. The
infectious dose is low; ingestion of 10 cysts has been reported
to cause infection (6). Infected persons have been reported to
shed <109 cysts in their stool per day and to excrete cysts for
months (6–8).
Persons at increased risk for infection include 1) travelers to
disease-endemic areas; 2) children in child care settings; 3)
close contacts of infected persons (e.g., those in the same fam-
ily or household or in the child care setting); 4) persons who
ingest contaminated drinking water; 5) persons who swallow
contaminated recreational water (e.g., water in lakes, rivers,
and pools); 6) persons taking part in outdoor activities (e.g.,
backpacking and camping) who consume unfiltered, untreated
water or who fail to practice hygienic behaviors (e.g., hand
washing); 7) persons who have contact with infected animals;
and 8) men who have sex with men (2,9–13). The relative
contribution of person-to-person, animal-to-person,
foodborne, and waterborne transmission to sporadic human
giardiasis in the United States is unknown.
Introduction
Giardia intestinalis (also known as G. lamblia and
G. duodenalis) is the most common intestinal parasite identi-
fied by public health laboratories in the United States (1).
This flagellated protozoan causes clinical illness (i.e., giardia-
sis) characterized by diarrhea, abdominal cramps, bloating,
weight loss, and malabsorption; however, asymptomatic
infection also frequently occurs (2–4). Case reports indicate
that giardiasis also might be associated with the development
of reactive arthritis (5). A zoonotic disease, giardiasis also
affects domestic and wild mammals (e.g., cats, dogs, cattle,
deer, and beavers) (2).
Giardia infection is transmitted by the fecal-oral route and
results from the ingestion of Giardia cysts through the con-
sumption of fecally contaminated food or water or through
Corresponding author: Michael J. Beach, PhD, Epidemiologist, CDC/
NCID/DPD, 1600 Clifton Rd., NE, MS F-22, Atlanta, GA 30341; Fax:
770-488-7761; E-mail: mjb3@cdc.gov.
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Although giardiasis cases can occur sporadically, outbreaks
are well documented. During 1991–2000, Giardia was iden-
tified as a causal agent of 9.4% (10 of 106) of reported recre-
ational water-associated and 16.2% (21 of 130) of reported
drinking water-associated outbreaks of gastroenteritis of known
or suspected infectious etiology* (13–17). Additionally,
foodborne outbreaks of giardiasis linked to infected
foodhandlers and uninfected foodhandlers who diapered
infected children have been reported (18). Outbreaks result-
ing from person-to-person transmission in child care centers
also have been reported (19).
In 1992, the Council of State and Territorial Epidemiolo-
gists (CSTE) assigned giardiasis an event code (code 11570)
to facilitate transmission of reported giardiasis data to CDC.
Reporting of giardiasis as a nationally notifiable disease began
in 2002. This report summarizes national giardiasis surveil-
lance data for 1998–2002.
Methods
Laboratory-confirmed and probable cases of giardiasis can
be reported voluntarily to CDC. Laboratory-confirmed giar-
diasis is defined as the detection (in symptomatic or asymp-
tomatic persons) of Giardia intestinalis
• cysts in stool specimens or trophozoites in stool speci-
mens, duodenal fluid, or small-bowel tissue by microscopic
examination using staining methods (e.g., trichrome) or
direct fluorescent antibody assays (DFA); or
• antigens in stool specimens by immunodiagnostic testing
(e.g., enzyme-linked immunosorbent assay) (20).
A probable case of giardiasis is a clinically compatible case
that is linked epidemiologically to a laboratory-confirmed case
(20). DFA is the most sensitive and specific detection method
for Giardia (21). Because Giardia cysts can be excreted inter-
mittently, and multiple stool collections increase testing sen-
sitivity, a total of three stool specimens should be collected,
each on a different day (22).
State, District of Columbia (DC), New York City (NYC),
commonwealth, and territorial health departments can volun-
tarily report laboratory-confirmed and probable cases of
giardiasis to CDC through the National Electronic Telecom-
munications System for Surveillance (NETSS). Reports include
the patient’s geographic information (i.e., state and county),
age, sex, race, ethnicity (i.e., Hispanic or non-Hispanic), and
date of illness onset and indicate whether the case is related to a
known outbreak. An outbreak-related case is a laboratory-
confirmed or a probable case that is linked epidemiologically to
a laboratory-confirmed case.
Analysis of the national giardiasis surveillance data for 1998–
2002 was conducted by using SAS® v 8.2 (SAS Institute, Inc.;
Cary, North Carolina) and the Food Safety Information Link
(FSI Link). FSI Link, an intranet-based tool available to CDC
staff, provides access to NETSS data and is used to monitor
trends in and investigate outbreaks of reportable foodborne
and waterborne diseases.
Results
During the 1998–2002 reporting period, the total number
of reported cases of giardiasis decreased 18.6% from 24,226
for 1998 to 19,708 for 2001 and then increased 8.1% to
21,300 for 2002 (Table 1). Cases reported to be outbreak
related made up 1.6%–11.6% of the total number of cases
reported annually for 1999–2002. Although the number of
states reporting cases increased from 42 to 46 during the
reporting period, the number of states reporting >15 cases
per 100,000 population decreased from 10 in 1998 to five in
2002.
For 2002, among states reporting cases, incidence of giar-
diasis ranged from <0.1 cases (Texas) to 23.5 cases (Vermont)
per 100,000 population. Vermont reported the greatest num-
ber of cases per 100,000 population for each of the 5 years of
the reporting period. Northern states reported more cases
annually per 100,000 population than southern states
(Figure 1) (Table 1).
These surveillance data display a bimodal age distribution,
with the greatest number of reported cases occurring among
children aged 1–9 years and adults aged 30–39 years (Figure 2).
When reports for which patients’ sex was missing or unknown
are excluded, the percentage of cases reported to have occurred
among males varied annually from 52.0% (12,125 of 23,310)
for 1998 to 55.8% (10,851 of 19,460) for 2001.
A twofold increase in reported giardiasis cases by onset of
illness occurred during June–October (i.e., weeks 26–42 [early
summer through early fall]) compared with January–March
(Figure 3). However, the date of onset of illness was indicated
for only 43.3% (10,480 of 24,226) of reported cases for 1998,
for 43.8% (10,197 of 23,281) for 1999, for 42.6% (9,290 of
21,813) for 2000, for 49.2% (9,692 of 19,708) for 2001, and
for 48.1% (10,245 of 21,300) for 2002. Age-specific analysis
indicated that the seasonality in onset of illness was exhibited
among children aged 1–4 and 5–9 years and adults aged 35–39
years (Figure 4) and among all age groups.
* The denominator includes outbreaks whose etiology was reported as acute
gastrointestinal illness because they were suspected to be caused by an
unidentified infectious agent.
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TABLE 1. Giardiasis case reports, by state/area — United States, 1998–2002
1998 1999 2000 2001 2002
No. No. No. No. No.
of out- of out- of out- of out- of out-
break break break break break
State/Area No. (%) Rate* cases No. (%) Rate cases No. (%) Rate cases No. (%) Rate cases No. (%) Rate cases
Alabama 288 (1.2) 6.6 340 (1.5) 7.8 227 (1.0) 5.1 231 (1.2) 5.2 205 (1.0) 4.6
Alaska 109 (0.4) 17.7 96 (0.4) 15.5 115 (0.5) 18.3 121 (0.6) 19.1 115 (0.5) 17.9 21
Arizona 250 (1.0) 5.4 255 (1.1) 5.3 313 (1.4) 6.1 267 (1.4) 5.0 2 269 (1.3) 4.9 1
Arkansas 168 (0.7) 6.6 152 (0.7) 6.0 203 (0.9) 7.6 160 (0.8) 5.9 175 (0.8) 6.5
California NR† NR NR NR 2,561 (12.0) 7.3
Colorado 618 (2.6) 15.6 704 (3.0) 17.4 4 695 (3.2) 16.2 5 632 (3.2) 14.3 2 571 (2.7) 12.7 5
Connecticut NR NR 462 (2.1) 13.6 417 (2.1) 12.1 260 (1.2) 7.5
Delaware 39 (0.2) 5.2 52 (0.2) 6.9 92 (0.4) 11.7 59 (0.3) 7.4 54 (0.3) 6.7
District of Columbia 34 (0.1) 6.5 37 (0.2) 7.1 38 (0.2) 6.6 70 (0.4) 12.2 47 (0.2) 8.3
Florida 1,676 (6.9) 11.2 1,636 1,360 (5.8) 9.0 1,334 1,521 (7.0) 9.5 1,459 1,155 (5.9) 7.1 1,318 (6.2) 7.9 1,226
Georgia 1,215 (5.0) 15.9 1,355 (5.8) 17.4 1,201 (5.5) 14.7 963 (4.9) 11.5 926 (4.3) 10.8
Hawaii 123 (0.5) 10.3 99 117 (0.5) 9.9 117 105 (0.5) 8.7 105 118 (0.6) 9.6 118 91 (0.4) 7.3 91
Idaho 177 (0.7) 14.4 1 134 (0.6) 10.7 1 139 (0.6) 10.7 172 (0.9) 13.0 1 137 (0.6) 10.2 1
Illinois 1,472 (6.1) 12.2 1,458 (6.3) 12.0 11 1,093 (5.0) 8.8 1,108 (5.6) 8.9 1,011 (4.8) 8.0
Indiana 772 (3.2) 13.1 654 (2.8) 11.0 3 517 (2.4) 8.5 3 (<0.1) <0.1 NR
Iowa 429 (1.8) 15.0 4 377 (1.6) 13.1 420 (1.9) 14.4 345 (1.8) 11.8 314 (1.5) 10.7
Kansas 226 (0.9) 8.6 7 220 (0.9) 8.3 205 (0.9) 7.6 178 (0.9) 6.6 192 (0.9) 7.1
Kentucky NR NR NR NR NR
Louisiana NR 21 (0.1) 0.5 41 (0.2) 0.9 14 (0.1) 0.3 6 (<0.1) 0.1
Maine 277 (1.1) 22.2 238 (1.0) 19.0 238 (1.1) 18.7 197 (1.0) 15.3 1 213 (1.0) 16.4
Maryland NR 119 (0.5) 2.3 125 (0.6) 2.4 8 NR 118 (0.6) 2.2 5
Massachusetts 833 (3.4) 13.6 637 851 (3.7) 13.8 640 632 (2.9) 10.0 12 908 (4.6) 14.2 27 935 (4.4) 14.6 1
Michigan 1,172 (4.8) 11.9 8 1,166 (5.0) 11.8 2 1,135 (5.2) 11.4 1 1,003 (5.1) 10.0 1 923 (4.3) 9.2
Minnesota 1,324 (5.5) 28.0 8 1,555 (6.7) 32.6 9 1,227 (5.6) 24.9 22 1,061 (5.4) 21.3 16 982 (4.6) 19.5
Mississippi 131 (0.5) 4.8 131 145 (0.6) 5.2 116 (0.5) 4.1 NR NR
Missouri 790 (3.3) 14.5 807 (3.5) 14.8 839 (3.8) 15.0 715 (3.6) 12.7 512 (2.4) 9.0
Montana 119 (0.5) 13.5 2 83 (0.4) 9.4 1 91 (0.4) 10.1 1 95 (0.5) 10.5 94 (0.4) 10.3
Nebraska 249 (1.0) 15.0 238 (1.0) 14.3 300 (1.4) 17.5 1 234 (1.2) 13.6 191 (0.9) 11.1
Nevada 222 (0.9) 12.7 140 215 (0.9) 11.9 121 211 (1.0) 10.6 138 208 (1.1) 9.9 162 (0.8) 7.5
New Hampshire 83 (0.3) 7.0 83 64 (0.3) 5.3 64 56 (0.3) 4.5 56 38 (0.2) 3.0 38 46 (0.2) 3.6 46
New Jersey 218 (0.9) 2.7 NR NR 494 (2.5) 5.8 474 (2.2) 5.5
New Mexico 238 (1.0) 13.7 261 (1.1) 15.0 1 164 (0.8) 9.0 148 (0.8) 8.1 153 (0.7) 8.3
New York§ 3,739 (15.4) 20.6 55 3,696 (15.9) 20.3 78 3,346 (15.3) 17.6 83 2,903 (14.7) 15.2 66 2,764 (13.0) 14.4 80
New York City 2,079 (8.6) 28.1 1,894 (8.1) 25.5 1,737 (8.0) 21.7 1,520 (7.7) 18.9 1,417 (6.7) 17.6
North Carolina NR NR NR NR NR
North Dakota 82 (0.3) 12.9 104 (0.4) 16.4 65 (0.3) 10.1 78 (0.4) 12.3 47 (0.2) 7.4
Ohio 1,093 (4.5) 9.7 1 1,110 (4.8) 9.9 2 1,058 (4.9) 9.3 1 1,090 (5.5) 9.6 1 972 (4.6) 8.5 6
Oklahoma 148 (0.6) 4.4 152 (0.7) 4.5 96 (0.4) 2.8 NR 85 (0.4) 2.4
Oregon 900 (3.7) 27.4 808 (3.5) 24.4 2 654 (3.0) 19.1 13 543 (2.8) 15.6 4 447 (2.1) 12.7 4
Pennsylvania 1,461 (6.0) 12.2 2 1,124 (4.8) 9.4 4 1,083 (5.0) 8.8 10 1,150 (5.8) 9.4 8 1,066 (5.0) 8.6 1
Rhode Island 130 (0.5) 13.2 149 (0.6) 15.0 157 (0.7) 15.0 168 (0.9) 15.9 170 (0.8) 15.9
South Carolina NR NR NR NR 149 (0.7) 3.6
South Dakota 181 (0.7) 24.8 143 (0.6) 19.5 5 108 (0.5) 14.3 16 106 (0.5) 14.0 15 83 (0.4) 10.9 7
Tennessee 220 (0.9) 4.0 187 (0.8) 3.4 187 (0.9) 3.3 189 (1.0) 3.3 191 (0.9) 3.3
Texas NR NR NR NR 3 (<0.1) <0.1
Utah 291 (1.2) 13.9 256 (1.1) 12.0 19 281 (1.3) 12.6 42 284 (1.4) 12.5 3 335 (1.6) 14.4
Vermont 326 (1.3) 55.2 345 (1.5) 58.1 30 217 (1.0) 35.6 220 (1.1) 35.9 145 (0.7) 23.5
Virginia 503 (2.1) 7.4 471 (2.0) 6.9 1 437 (2.0) 6.2 417 (2.1) 5.8 386 (1.8) 5.3
Washington 740 (3.1) 13.0 560 (2.4) 9.7 622 (2.9) 10.6 512 (2.6) 8.5 510 (2.4) 8.4
West Virginia 90 (0.4) 5.0 4 93 (0.4) 5.1 1 80 (0.4) 4.4 3 83 (0.4) 4.6 78 (0.4) 4.3
Wisconsin 1,003 (4.1) 19.2 936 (4.0) 17.8 10 811 (3.7) 15.1 3 765 (3.9) 14.2 12 691 (3.2) 12.7 5
Wyoming 45 (0.2) 9.4 37 (0.2) 7.7 49 (0.2) 9.9 1 37 (0.2) 7.5 1 29 (0.1) 5.8
Total state 24,204 (99.9) 9.0 2,818 23,245 (99.8) 8.5 2,460 21,772 (99.8) 7.7 1,980 19,659 (99.8) 6.9 316 21,206 (99.6) 7.4 1,500
Guam 9 (<0.1) 6.0 23 (0.1) 15.1 17 (0.1) 10.9 9 (<0.1) 5.7 7 (<0.1) 4.3
Northern Mariana
Islands NR — NR — NR — NR — 1 (<0.1) 1.4
Puerto Rico 13 (0.1) 0.3 13 (0.1) 0.3 24 (0.1) 0.6 40 (0.2) 1.0 3 86 (0.4) 2.2 2
Total 24,226 (100.0)¶ 2,818 23,281 (100.0) 2,460 21,813 (100.0) 1,980 19,708 (100.0) 319 21,300 (100.0) 1,502
Sources: Population estimates are from the Population Division, US Census Bureau. Estimates of the population of states: ST-99-4 State Rankings of Population Change and
Demographic Components of Population Change for the Period July 1, 1998, to July 1, 1999, available at http://www.census.gov/popest/archives/1990s/ST-99-01.txt, and Table 1:
Annual estimates of the population for the United States and States and Puerto Rico: April 1, 2001, to July 1, 2003 (NST-EST 2003 01), available at http://www.census.gov/popest/
states/tables/NST-EST2003-01.xls. Estimates of the New York City population: (SU-99-7) Population Estimates for Places (Sorted Alphabetically Within State): Annual Time Series,
July 1, 1990, to July 1, 1999 (includes April 1, 1990 Population Estimates Base), available at http://www.census.gov/popest/archives/1990s/su-99-07/SU-99-7_NY.txt, and Table 1:
Annual Estimates of the Population for Incorporated Places over 100,000, Ranked by July 1, 2003 Population: April 1, 2001, to July 1, 2003 (SUB-EST 2003-01), available at
http://www.census.gov/popest/cities/tables/SUB-EST2003-01.xls. Estimates of the population of Guam, the Northern Mariana Islands, and Puerto Rico: International Data Base (IDB)
Data Access — Spreadsheet, available at http://www.census.gov/ipc/www/idbsprd.html.
* Per 100,000 population on the basis of U.S. Census Bureau population estimates.
† No cases reported to CDC.
§ New York State counts include New York City cases.
¶ Percentages might not total 100% because of rounding.
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The majority of cases for which data on race were available
for 1998–2002 occurred among whites, followed by blacks,
Asians and Pacific Islanders, and Native Americans (Table 2).
However, data on race were not included for 39.2%–46.8%
of total annual case reports. Of patients for whom data on
ethnicity were reported, 13.6%–16.3% (1,651 of 12,158 for
1998 and 1,526 of 9,361 for 2001, respectively) were reported
to be Hispanic. However, data on ethnicity were lacking for
49.5%–54.5% of total annual case reports for 1998–2002.
Discussion
National giardiasis surveillance data
are used to assess the epidemiologic char-
acteristics and disease burden of giardia-
sis in the United States. The total number
of cases reported annually decreased dur-
ing 1998–2001 and then increased in
2002. Reporting of giardiasis as a nation-
ally notifiable disease began in 2002.
California, which reported giardiasis
cases for the first time in 2002, recorded
2,561 cases, which likely explains the
observed increase in case reports for that
year. Whether the decrease in reported
cases for 1999–2001 reflects changes in
reporting patterns and behavior or a real
change in infection and disease caused
by Giardia is unclear. FoodNet data
document a decrease in case reports of
other enteric diseases for 1996–2003;
FIGURE 1. Incidence* of giardiasis, by state — United States,
2002
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† No cases reported to CDC.
NR
7.5
7.6–15.0
15.1–22.5
22.6
†
<
>
District of
Columbia
New York
City
* In 1,000s.
† Case reports decreased with increased age.
FIGURE 2. Number* of giardiasis case reports, by age group and year — United
States, 1998–2002
<1 1–4 5–9 10–14 15–19 20–24 25–29 30–34 35–39 40–44 45–49 50–54 55–59 >60†
Age group (yrs)
1998
1999
2000
2001
2002
0
1
2
3
4
5
6
N
um
be
r
this decrease has been attributed to increased government and
food industry emphasis on improved food safety (23).
Giardiasis is geographically widespread in the United States.
These data and data from the previous national giardiasis sur-
veillance summary (1992–1997) indicate that the diagnosis
or transmission of giardiasis might be higher in northern states
(24). However, because differences in giardiasis surveillance
systems among states can affect the capability to detect cases,
whether this finding is of true biologic significance or is only
the result of differences in case detection or reporting is diffi-
cult to determine.
Although giardiasis affects persons in all age groups, the
number of reported cases was highest among children aged
1–9 years and adults aged 30–39 years. These data are consis-
tent with previously published reports of giardiasis incidence
being higher among younger children and of transmission to
their caregivers (e.g., child care staff, family members, and
other household contacts) (2,24–26).
A marked seasonality in the onset of illness occurs in early
summer through early fall, and a twofold increase in trans-
mission of giardiasis occurs during the summer. This increase
coincides with increased outdoor activities (e.g., swimming
during the summer recreational water season and camping)
and might reflect heavy use of community swimming (essen-
tially communal bathing) venues by younger children. Trans-
mission through use of surface water (e.g., lakes and rivers)
and disinfected venues (e.g., swimming pools and water parks)
is facilitated by the substantial number of Giardia cysts that
can be shed by a single person; the extended periods of time
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that cysts can be shed; the low infectious dose; the moderate
resistance to chlorine of Giardia; the prevalence of improper
pool maintenance (i.e., insufficient disinfection, filtration,
and recirculation of water), particularly of children’s wading
pools; the prevalence of Giardia in fecal material in pools;
and documented transmission of Giardia infection among
diapered children using swimming venues (6–8,27–29). This
seasonal variation also has been noted in state, Canadian pro-
vincial, and previous U.S. national surveillance data for giar-
diasis, as well as for cryptosporidiosis (24–26,30).
Among patients for whom data on sex were reported, the
proportion reported to be male increased annually during
1998–2001. However, because 12.9% of case reports for 2002
did not include data about sex, whether this increase contin-
ued in 2002 is unclear. Because data on race and ethnicity are
incomplete, conclusions cannot be made about the differences
noted in the epidemiology of giardiasis among members of
different racial populations and between Hispanics and non-
Hispanics.
TABLE 2. Number and percentage* of giardiasis case reports, by selected demographic characteristics — United States, 1998–2002
1998 1999 2000 2001 2002
Characteristic No. (%) No. (%) No. (%) No. (%) No. (%)
Sex
  Male 12,125 (50.0) 12,220 (52.5) 11,726 (53.8) 10,851 (55.1) 10,182 (47.8)
  Female 11,185 (46.2) 10,718 (46.0) 9,808 (45.0) 8,609 (43.7) 8,374 (39.3)
  Unknown/Missing 916 (3.8) 343 (1.5) 279 (1.3) 248 (1.3) 2,744 (12.9)
  Total 24,226 (100.0) 23,281 (100.0) 21,813 (100.0) 19,708 (100.0) 21,300 (100.0)
Race
  Native American 95 (0.4) 98 (0.4) 71 (0.3) 197 (1.0) 76 (0.4)
  Asian/Pacific Islander 586 (2.4) 499 (2.1) 515 (2.4) 497 (2.5) 498 (2.3)
  Black 932 (3.8) 958 (4.1) 1,159 (5.3) 1,035 (5.3) 808 (3.8)
  White 12,873 (53.1) 12,418 (53.3) 11,404 (52.3) 9,676 (49.1) 9,853 (46.3)
  Other 66 (0.3) 104 (0.4) 123 (0.6) 114 (0.6) 99 (0.5)
  Unknown/Missing 9,674 (39.9) 9,204 (39.5) 8,541 (39.2) 8,189 (41.6) 9,966 (46.8)
  Total 24,226 (100.0) 23,281 (100.0) 21,813 (100.0) 19,708 (100.0) 21,300 (100.0)
Ethnicity
  Hispanic 1,651 (6.8) 1,627 (7.0) 1,673 (7.7) 1,526 (7.7) 1,486 (7.0)
  Non-Hispanic 10,507 (43.4) 10,094 (43.4) 9,336 (42.8) 7,835 (39.8) 8,206 (38.5)
  Unknown/Missing 12,068 (49.8) 11,560 (49.7) 10,804 (49.5) 10,347 (52.5) 11,608 (54.5)
  Total 24,226 (100.0) 23,281 (100.0) 21,813 (100.0) 19,708 (100.0) 21,300 (100.0)
* Percentages might not total 100% because of rounding.
FIGURE 3. Number* of giardiasis case reports, by date of
illness onset — United States, 1998–2002
* In 1,000s.
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FIGURE 4. Number of giardiasis case reports, by selected
age group* and date of illness onset — United States, 1998–
2002
* The three age groups (1–4, 5–9, and 35–39 years) with the highest numbers
of giardiasis case reports are presented. All age groups exhibited a twofold
increase.
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The data reported likely underestimate the giardiasis bur-
den in the United States. Diarrheal diseases are highly
underreported because 1) not all infected persons are symp-
tomatic; 2) those who are symptomatic do not always seek
medical care; 3) health-care providers do not always include
diagnostics in their workup of diarrheal diseases because they
might treat patients without testing stool for the pathogen;
and 4) case reports are not always completed for positive labo-
ratory results or forwarded to public health officials (31).
An estimated 1%–5% of cases of salmonellosis, another diar-
rheal illness, are reported to CDC through passive surveillance
(32). If these estimates are used to extrapolate from the 21,206
giardiasis cases reported by the 50 states and DC for 2002, the
giardiasis disease burden in the United States in 2002 could
have been 424,120–2,120,600 cases (147.3–736.4 cases per
100,000 population). The true burden of giardiasis in the United
States is likely to fall between these two estimates.
Its low infectious dose, protracted communicability, and
moderate chlorine resistance make Giardia ideally suited for
transmission through drinking and recreational water, food,
and both person-to-person and animal-to-person contact.
Prevention measures (Box 1) and measures to improve sur-
veillance for giardiasis and increase understanding of its epi-
demiology and the associated disease burden (Box 2) have
been recommended. Information about giardiasis is available
from CDC at http://www.cdc.gov/ncidod/dpd/parasites/gia-
rdiasis/factsht_giardia.htm.
BOX 1. Recommendations to prevent and control giardiasis
Always practice good hand hygiene.
• Wash hands with soap and water for at least 15 seconds,
rubbing hands together vigorously and scrubbing all
surfaces
— after using the toilet,
— before handling food,
— after every diaper change (even if wearing gloves),
— after direct contact with preschool-aged children,
and
— after any contact with animals or their feces.
Prevent contamination of recreational water (e.g.,
swimming pools, spas, interactive fountains, lakes,
rivers, and oceans).
• Do not swim when ill with diarrhea (e.g., swimming in
or entering the water at pools, spas, interactive foun-
tains, lakes, rivers, or oceans).
• Take children on frequent bathroom breaks and check
their diapers often.
• Change diapers in the bathroom, not at the poolside.
• Wash children thoroughly (especially their bottoms) with
soap and water after they use the toilet or their diapers
are changed and before they enter the water.
• Shower before entering the water.
Information about recreational water illnesses (RWIs)
and how to stop them from spreading is available from
CDC at http://www.cdc.gov/healthyswimming.
Prevent infection and illness caused by water that might
be contaminated.
• Do not swallow water in swimming pools, spas, and
interactive fountains.
• Do not swallow untreated water from lakes, rivers,
springs, ponds, streams, or shallow wells.
• Do not drink inadequately treated water during community-
wide outbreaks caused by contaminated drinking water.
• Do not use or drink inadequately treated water when
traveling in countries where the water supply might be
unsafe.
• If the safety of drinking water is in doubt,
— disinfect it by heating the water to a rolling boil for
1 minute,
— use a filter that has been tested and rated by
National Safety Foundation (NSF) Standard 53 or
NSF Standard 58 for cyst reduction (filtered water
will need additional treatment to kill or inactivate
bacteria and viruses), or
— treat it with chlorine or iodine; however, these
chemical methods are less effective against Giardia
than boiling or filtering because they are highly
dependent on the temperature, pH, and cloudiness
of the water.
Prevent infection and illness caused by eating food that
might be contaminated.
• Use properly treated water to wash all food that will be
eaten raw.
• Do not eat uncooked foods when traveling in areas where
giardiasis is common.
Prevent contact and contamination with feces during
sex.
• Use a barrier (e.g., a condom) during oral-anal sex.
• Wash hands immediately after handling a condom used
during anal sex and after touching the anus or rectal
area.
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